Browsing: Inhibrx

Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million

By

SAN DIEGO, July 16, 2026 /PRNewswire/ — Inhibrx Biosciences, Inc. (“Inhibrx” or the “Company”) (Nasdaq: INBX), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, today announced it entered into the Second Amendment (the “Second Amendment”) to the Loan and Security Agreement, as amended (the “Amended LSA”) with Oxford Finance LLC (“Oxford,” together…